Interleukin-6 functions as an autocrine growth factor in human bladder carcinoma cell lines in vitro

89Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Interleukin (IL)-6 is reported to function as a growth factor for renal and prostatic carcinomas. We conducted the present study to define the role of IL-6 in the growth of normal and neoplastic urothelial cells. Human bladder carcinoma cell lines (253J, RT4 and T24) and primary cultured human urothelial cells derived from normal ureters were used. Recombinant human IL- 6 stimulated the growth of bladder carcinoma cell lines far better than that of normal urothelial cells (p < 0.001). All carcinoma cell lines tested produced and released IL-6, whereas normal urothelial cells did so only at marginal levels. Furthermore, treatment with lipopolysaccharide derived from Escherichia coli tumor necrosis factor-α or IL-1 increased IL-6 secretion by bladder carcinoma cell lines but not by normal urothelial cells. Growth of bladder carcinoma cells was significantly inhibited by anti-IL-6 neutralizing antibody or the anti-sense oligonucleotide for IL-6 cDNA. We conclude that IL-6 functions as an autocrine growth factor for bladder carcinoma cells but not for normal urothelial cells and that it may be a factor accounting for the marked enhancement of inflammation-associated bladder carcinogenesis and tumor growth.

Cite

CITATION STYLE

APA

Okamoto, M., Hattori, K., & Oyasu, R. (1997). Interleukin-6 functions as an autocrine growth factor in human bladder carcinoma cell lines in vitro. International Journal of Cancer, 72(1), 149–154. https://doi.org/10.1002/(SICI)1097-0215(19970703)72:1<149::AID-IJC21>3.0.CO;2-D

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free